Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug: pharmacokinetic consideration

J Toxicol Sci. 1996 Dec;21(5):309-16. doi: 10.2131/jts.21.5_309.
No abstract available

Publication types

  • Review

MeSH terms

  • Drug Design*
  • Drug Interactions
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Pharmaceutical Preparations / metabolism*
  • Pharmacokinetics*
  • Product Surveillance, Postmarketing
  • Risk Assessment


  • Pharmaceutical Preparations